Please provide your email address to receive an email when new articles are posted on . Mitral annulus calcification may be an independent risk factor for all-cause mortality and was more common among ...

ROCHESTER, Minn. — A retrospective review of more than 24,000 patients who underwent an EKG at Mayo Clinic finds that nearly one-quarter of the patients had mitral annulus calcification, a chronic ...

A retrospective review of more than 24,000 patients who underwent an EKG at Mayo Clinic finds that nearly one-quarter of the patients had mitral annulus calcification, a chronic degeneration of tissue ...

Employing intravascular lithotripsy facilitated transcatheter mitral valve replacement in a patient with severe mitral annular and mitral valve leaflet calcification, according to a report on a ...

Patients with mitral annulus calcification are at more than double the risk for mitral valve dysfunction, a study published June 1 in Mayo Clinic Proceedings found. Researchers retrospectively ...

Transcatheter implantation of the Tendyne mitral valve replacement device for treatment of mitral regurgitation in patients at prohibitive surgical risk because of severe mitral annular calcification ...

Mitral valve regurgitation is a heart condition that occurs when the mitral valve does not close properly, allowing blood to flow backward into the left atrium. Symptoms do not always occur. When they ...

Mitral valve prolapse is a condition affecting the heart. Doctors may also call it floppy mitral valve syndrome or systolic click-murmur syndrome. It stems from a mitral valve malfunction, which may ...

By Shimona Patel: Understanding how the heart’s valves function is key to recognising certain cardiovascular conditions. One such condition is mitral valve regurgitation, where the valve between the ...

Mitral valve prolapse treatments include medication to manage symptoms, lifestyle changes, and in people with severe cases, surgical intervention to repair or replace the mitral valve. Mitral valve ...

SALT LAKE CITY--(BUSINESS WIRE)--Foldax®, Inc. today announced the successful first-in-human use of its biopolymer Tria™ heart valve in surgically replacing a diseased mitral valve. The first case was ...